AEGON ASSET MANAGEMENT UK Plc trimmed its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 16.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 353,699 shares of the industrial products company's stock after selling 69,676 shares during the period. AEGON ASSET MANAGEMENT UK Plc owned about 0.15% of Xylem worth $47,732,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Russell Investments Group Ltd. increased its stake in shares of Xylem by 12.9% during the first quarter. Russell Investments Group Ltd. now owns 338,315 shares of the industrial products company's stock worth $43,737,000 after buying an additional 38,603 shares during the period. California State Teachers Retirement System increased its stake in Xylem by 1.4% in the first quarter. California State Teachers Retirement System now owns 393,856 shares of the industrial products company's stock valued at $50,902,000 after purchasing an additional 5,477 shares during the last quarter. Cetera Investment Advisers increased its stake in Xylem by 191.7% in the first quarter. Cetera Investment Advisers now owns 27,412 shares of the industrial products company's stock valued at $3,543,000 after purchasing an additional 18,014 shares during the last quarter. Edgestream Partners L.P. increased its stake in Xylem by 82.6% in the first quarter. Edgestream Partners L.P. now owns 25,070 shares of the industrial products company's stock valued at $3,240,000 after purchasing an additional 11,344 shares during the last quarter. Finally, BOKF NA increased its stake in Xylem by 967.9% in the first quarter. BOKF NA now owns 68,941 shares of the industrial products company's stock valued at $8,869,000 after purchasing an additional 62,485 shares during the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Xylem Stock Performance
Shares of NYSE XYL traded up $0.71 during mid-day trading on Friday, hitting $124.37. 884,582 shares of the company were exchanged, compared to its average volume of 1,191,867. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. The stock has a 50 day simple moving average of $131.47 and a 200-day simple moving average of $134.97. Xylem Inc. has a 1-year low of $96.61 and a 1-year high of $146.08. The firm has a market cap of $30.22 billion, a price-to-earnings ratio of 36.36, a price-to-earnings-growth ratio of 2.28 and a beta of 1.05.
Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, meeting analysts' consensus estimates of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The company had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $2.17 billion. During the same quarter last year, the company earned $0.99 earnings per share. Xylem's quarterly revenue was up .2% compared to the same quarter last year. On average, sell-side analysts forecast that Xylem Inc. will post 4.23 EPS for the current fiscal year.
Xylem Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date was Thursday, August 29th. Xylem's dividend payout ratio (DPR) is currently 42.11%.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on the stock. TD Cowen dropped their price target on shares of Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a research note on Wednesday. Royal Bank of Canada decreased their price objective on Xylem from $163.00 to $162.00 and set an "outperform" rating for the company in a report on Friday, November 1st. UBS Group started coverage on Xylem in a report on Tuesday, August 13th. They issued a "buy" rating and a $165.00 price objective for the company. Stifel Nicolaus increased their price objective on Xylem from $170.00 to $172.00 and gave the company a "buy" rating in a report on Wednesday, July 31st. Finally, Robert W. Baird decreased their price objective on Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $147.17.
View Our Latest Stock Analysis on XYL
Xylem Company Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.